<!DOCTYPE html>
<!--[if lt IE 7]> <html lang="en" class="ie ie6 lte9 lte8 lte7 os-other"> <![endif]-->
<!--[if IE 7]> <html lang="en" class="ie ie7 lte9 lte8 lte7 os-other"> <![endif]-->
<!--[if IE 8]> <html lang="en" class="ie ie8 lte9 lte8 os-other"> <![endif]-->
<!--[if IE 9]> <html lang="en" class="ie ie9 lte9 os-other"> <![endif]-->
<!--[if gt IE 9]> <html lang="en" class="os-other"> <![endif]-->
<!--[if !IE]><!--> <html lang="en" class="os-other"> <!--<![endif]-->
<head>
<script src="http://static.licdn.com:80/scds/common/u/lib/fizzy/fz-1.3.6-min.js" type="text/javascript"></script><script type="text/javascript">fs.config({"failureRedirect":"http://www.linkedin.com/nhome/","uniEscape":true,"xhrHeaders":{"X-FS-Origin-Request":"/in/timmaguire","X-FS-Page-Id":"nprofile-public-vanity"}});</script><script></script>
<meta name="globalTrackingUrl" content="//www.linkedin.com/mob/tracking">
<meta name="globalTrackingAppName" content="profile">
<meta name="globalTrackingAppId" content="webTracking">
<meta name="lnkd-track-json-lib" content="http://s.c.lnkd.licdn.com/scds/concat/common/js?h=2jds9coeh4w78ed9wblscv68v-ebbt2vixcc5qz0otts5io08xv&amp;fc=2">
<meta name="lnkd-track-lib" content="http://s.c.lnkd.licdn.com/scds/concat/common/js?h=ebbt2vixcc5qz0otts5io08xv&amp;fc=2">
<meta name="treeID" content="eqyoDhdxnxMw4UU0lCsAAA==">
<meta name="appName" content="profile">
<meta name="lnkd-track-error" content="/lite/ua/error?csrfToken=ajax%3A3149088565232137545">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="pageImpressionID" content="d2fd9ab8-0aca-4989-9545-f7c49fd36434">
<meta name="pageKey" content="nprofile-public-success">
<meta name="analyticsURL" content="/analytics/noauthtracker">
<link rel="apple-touch-icon-precomposed" href="http://s.c.lnkd.licdn.com/scds/common/u/img/icon/apple-touch-icon.png">
<!--[if lte IE 8]>
  <link rel="shortcut icon" href="http://s.c.lnkd.licdn.com/scds/common/u/images/logos/favicons/v1/16x16/favicon.ico">
<![endif]-->
<!--[if IE 9]>
  <link rel="shortcut icon" href="http://s.c.lnkd.licdn.com/scds/common/u/images/logos/favicons/v1/favicon.ico">
<![endif]-->
<link rel="icon" href="http://s.c.lnkd.licdn.com/scds/common/u/images/logos/favicons/v1/favicon.ico">
<meta name="msapplication-TileImage" content="http://s.c.lnkd.licdn.com/scds/common/u/images/logos/linkedin/logo-in-win8-tile-144_v1.png"/>
<meta name="msapplication-TileColor" content="#0077B5"/>
<meta name="application-name" content="LinkedIn"/>
<link rel="stylesheet" type="text/css" href="http://s.c.lnkd.licdn.com/scds/concat/common/css?h=3bifs78lai5i0ndyj1ew7316e-38so5ftc5lv2bbm0jf5rvv1qj-7mxyksftlcjzimz2r05hd289r-4uu2pkz5u0jch61r2nhpyyrn8-aze4ooami6s3kk293iv0zfky1-7poavrvxlvh0irzkbnoyoginp-4om4nn3a2z730xs82d78xj3be-mea0xb6thaagfbcx9i1vg82z-ct4kfyj4tquup0bvqhttvymms-9zbbsrdszts09by60it4vuo3q-cjn95l493mkfqfc06i462jhjl-8ti9u6z5f55pestwbmte40d9-ej816lvgg0knmb99hj57wpnqe-3pwwsn1udmwoy3iort8vfmygt-cfsam81o5sp3cxb7m0hs933c4&amp;fc=2">
<script type="text/javascript" src="http://s.c.lnkd.licdn.com/scds/concat/common/js?h=3nuvxgwg15rbghxm1gpzfbya2-35e6ug1j754avohmn1bzmucat-mv3v66b8q0h1hvgvd3yfjv5f-14k913qahq3mh0ac0lh0twk9v-dfoaudjrk6rbf82f45bz5crwi-62og8s54488owngg0s7escdit-c8ha6zrgpgcni7poa5ctye7il-djim7uyllidc9gta745y2wo5m-51dv6schthjydhvcv6rxvospp-d7z5zqt26qe7ht91f8494hqx5-e9rsfv7b5gx0bk0tln31dx3sq-2r5gveucqe4lsolc3n0oljsn1-8v2hz0euzy8m1tk5d6tfrn6j-b88qxy99s08xoes3weacd08uc-3bw8x2fd8pq6h9gc3gtrar7gw-ac8pg92mfnb2j836ntpvg1fsi-9wkskbn6s2q25rkbrnuwlqric-8vqvo1r7b0ag99we8a4gleai2-a5j90w6w30bxiqjlfqu3a04ao-b0otj9zjsih2zu4s3gxjejik2-czstax4e6y68hymdvqxpwe5so-b0fmwulzun5h9v3vouth2gf36-28z3ukvmh5r9vwyyw1m6jl0pm-1pa3tpaab6s85oxj5wgz5m0p7-7vr4nuab43rzvy2pgq7yvvxjk-4yhpyv3p9r574wkkbe8kcd2ou&amp;fc=2"></script>
<script type="text/javascript" src="http://s.c.lnkd.licdn.com/scds/concat/common/js?h=4zslye83akez5s4mf91hrq425-95d8d303rtd0n9wj4dcjbnh2c&amp;fc=2"></script>
<meta name="description" content="View Tim Maguire&#39;s professional profile on LinkedIn.  LinkedIn is the world&#39;s largest business network, helping professionals like Tim Maguire discover inside connections to recommended job candidates, industry experts, and business partners.">
<title>Tim Maguire | LinkedIn</title>
<meta name="robots" content="noarchive">
<link rel="canonical" href="https://www.linkedin.com/in/timmaguire"/>
<link rel="stylesheet" type="text/css" href="http://s.c.lnkd.licdn.com/scds/concat/common/css?h=bub7ne3nidm7kzsnst42oogim-dk7hqlxjwmf0a9kuko97hr6lv-efnwlv96zujghl3vut1jrhf1q-5xxmkfcm1ny97biv0pwj7ch69-85qolmm1gxv900q8thzvvwt77&amp;fc=2">
<script type="text/javascript" src="http://s.c.lnkd.licdn.com/scds/concat/common/js?h=d43qahhuvg0j5mlh4c2m9sipk-ew7wxbzv14lsc4vzkh2xrbzqn-dp1os5pzpoyifn8ljtjpfxrz-e17zy6z51dugr6fy4su92o7de-eq875keqggun9hoxzfhbanjes&amp;fc=2"></script>
</head>
<body dir="ltr" class="guest v2 public-profile chrome-v5 chrome-v5-responsive sticky-bg guest" id="pagekey-nprofile-public-success">
<input id="inSlowConfig" type="hidden" value="false"/>
<script type="text/javascript">document.body.className+=" js ";</script>
<div id="header">
<div class="wrapper">
<div id="nav-utility">
<div class="logo" id="logo-linkedin">
<a href="/home?trk=hb_logo" id="logo-href"><img src="http://s.c.lnkd.licdn.com/scds/common/u/img/logos/logo_linkedin_92x22.png" width="92" height="22" alt="LinkedIn"></a>
</div>
<ul class="menu">
<li id="nav-utility-join"><a href="https://www.linkedin.com/reg/join?trk=hb_join">Join Today</a></li>
<li id="nav-utility-auth"><a href="https://www.linkedin.com/uas/login?trk=hb_signin">Sign In</a></li>
</ul>
</div>
</div> </div>
<div id="body">
<div class="wrapper">
<div id="global-error">
</div>
<div id="main" class="profile grid-a">
<div id="content" class="resume hresume">
<div class="profile-header">
<div id="member-1" class="masthead vcard contact">
<h1>
<span id="name" class="n fn">
<span class="full-name"><span class="given-name">Tim</span> <span class="family-name">Maguire</span></span>
</span>
</h1>
<p class="headline-title title" style="display:block">
CEO at VascuLogic
</p>
<dl id="headline" class="demographic-info adr">
<dt>Location</dt>
<dd>
<span class="locality">
Greater New York City Area
</span>
</dd>
<dt>Industry</dt>
<dd class="industry">
Medical Devices
</dd>
</dl>
</div>
<div id="nprofile-overview" class="join-linkedin name-button">
<div class="header">
<h2>
<a href="https://www.linkedin.com/reg/join-pprofile?_ed=0_dHB8G4tKSI1eNkyEd3uBk2dzQE2AkVU1r9kHbXjxPZGWJlD5Jt4ZMf87SacJnJbVJsbATEPh4_pXSAKkE7FxXU3K4xzLc6JUFvuNUlJ3UuS&amp;trk=pprof-0-ts-view_full-0" rel="nofollow">
Join LinkedIn and access Tim Maguire&#8217;s full profile. It's free!
</a>
</h2>
</div>
<div class="content">
<p>As a LinkedIn member, you'll join 300 million other professionals who are sharing connections, ideas, and opportunities.</p>
<ul>
<li>See who you and <strong>Tim Maguire</strong> know in common</li>
<li>Get introduced to <strong>Tim Maguire</strong></li>
<li>Contact <strong>Tim Maguire</strong> directly</li>
</ul>
</div>
<p id="show-expanded" class="actions ">
<a class="btn-action" id="regform-show" href="https://www.linkedin.com/reg/join-pprofile?_ed=0_dHB8G4tKSI1eNkyEd3uBk2dzQE2AkVU1r9kHbXjxPZGWJlD5Jt4ZMf87SacJnJbVJsbATEPh4_pXSAKkE7FxXU3K4xzLc6JUFvuNUlJ3UuS&amp;trk=pprof-0-ts-view_full-0" rel="nofollow">
View Tim's full profile
</a>
</p>
</div>
</div>
<h2 class="section-title">Tim Maguire's Overview </h2>
<dl id="overview">
<dt id="overview-summary-current-title" class="summary-current" style="display:block">
Current
</dt>
<dd class="summary-current" style="display:block">
<ul class="current">
<li>
CEO
<span class="at">at </span>
<a class="company-profile-public" href="/company/vasculogic?trk=ppro_cprof"><span class="org summary">VascuLogic</span></a>
</li>
<li>
CEO
<span class="at">at </span>
Beau Ridge Pharmaceuticals
</li>
<li>
Director of Business Development
<span class="at">at </span>
Rutgers CIVET
</li>
</ul>
<div class="showhide-block" id="morecurr">
<ul class="current">
<li>
Associate Research Professor
<span class="at">at </span>
<a class="company-profile-public" href="/company/rutgers-university?trk=ppro_cprof"><span class="org summary">Rutgers University</span></a>
</li>
<li>
Adjunct Faculty
<span class="at">at </span>
<a class="company-profile-public" href="/company/harvard-medical-school?trk=ppro_cprof"><span class="org summary">Harvard Medical School</span></a>
</li>
</ul>
<p class="seeall showhide-link"><a href="#" id="morecurr-hide">see less</a></p>
</div>
<p class="seeall showhide-link"><a href="#" id="morecurr-show">see all</a></p>
</dd>
<dt id="overview-summary-past-title" class="summary-past" style="display:block">
Past
</dt>
<dd class="summary-past" style="display:block">
<ul class="past">
<li>
COO
<span class="at">at </span>
Hurel Corporation
</li>
<li>
Senior Research Chemical Engineer
<span class="at">at </span>
<a class="company-profile-public" href="/company/merck?trk=ppro_cprof"><span class="org summary">Merck</span></a>
</li>
</ul>
</dd>
<dt id="overview-summary-education-title" class="summary-education" style="display:block">
Education
</dt>
<dd class="summary-education" style="display:block">
<ul>
<li>
<a href="https://www.linkedin.com/edu/rutgers-the-state-university-of-new-jersey-new-brunswick-18874">Rutgers, The State University of New Jersey-New Brunswick</a>
</li>
<li>
<a href="https://www.linkedin.com/edu/rutgers-university-new-brunswick-18874">Rutgers University-New Brunswick</a>
</li>
</ul>
</dd>
<dt>
Connections
</dt>
<dd class="overview-connections">
<p>
<strong>500+</strong> connections
</p>
</dd>
<dt class="websites">Websites</dt>
<dd class="websites">
<ul>
<li>
<a href="/redir/redirect?url=http%3A%2F%2Fvasculogic%2Ecom%2F&amp;urlhash=r-f1" target="_blank" title="New window will open" name="overviewsite">
Company Website
</a>
</li>
<li>
<a href="/redir/redirect?url=http%3A%2F%2Fscienceunveiled%2Eblogspot%2Ecom%2F&amp;urlhash=v1ij" target="_blank" title="New window will open" name="overviewsite">
Personal Website
</a>
</li>
<li>
<a href="/redir/redirect?url=http%3A%2F%2Firtfoundation%2Eorg%2F&amp;urlhash=_rpv" target="_blank" title="New window will open" name="overviewsite">
My Non-Profit Company
</a>
</li>
</ul>
</dd>
</dl>
<script type="text/javascript">showHide.init('overview');</script>
<div class="section" id="profile-summary" style="display:block">
<div class="header">
<h2>
Tim Maguire's Summary
</h2>
</div>
<div class="content">
<p class=" description summary">
Dr. Maguire is a company founder, member of the Board of Directors, and currently President and Chief Executive Officer of VascuLogic LLC. He has led the company in these functions since its inception in 2010. Dr. Maguire transformed VascuLogic LLC from concept stage to a viable startup. Under Dr. Maguire&#x2019;s leadership, the company is poised for Series A financing, and has built a solid portfolio in image-based medical devices and point of care diagnostics.<br>
<br>
Prior to joining VascuLogic, Dr. Maguire has worked in the medical device and pharmaceutical industries for over 8 years in various roles of increased leadership and responsibility. These included positions within strategy, global manufacturing, business development, clinical R&amp;D, and commercial teams. He has extensive experience in product launches and life-cycle management including MK-1572, Liptruzet, Victrelis, and Ibris. Additionally Dr. Maguire has raised over $5M in early stage funding, from both private and institutional investors.<br>
<br>
Dr. Maguire is a doctoral graduate of the Department of Biomedical Engineering at Rutgers. His primary thesis focus was the design of scalable cellular therapeutic systems. In addition, at Rutgers, he conducted extensive work in the area of bioinformatics, and medical devices. In total Dr. Maguire has over 30 publications, 16 patent applications, and over 100 public presentations at a variety of high-impact conferences.<br>
<br>
Specialties: Entrepreneurship, Operations, Growth Strategy, Business Development, Financial Modeling, Capital Structure Assessment, Medical Devices, Pharmaceuticals, Biotechnology
</p>
</div>
</div>
<div class="section subsection-reorder" id="profile-experience" style="display:block">
<div class="header">
<h2>Tim Maguire's Experience
</h2>
</div>
<div class="content vcalendar">
<div>
<div>
<div class="position  first experience vevent vcard summary-current" style="display:block">
<a class="include" href="#name"></a>
<div class="postitle">
<h3 class="false">
<span class="title">CEO</span>
</h3>
<h4><strong>
<a class="company-profile-public" href="/company/vasculogic?trk=ppro_cprof"><span class="org summary">VascuLogic</span></a>
</strong></strong>
</h4>
</div>
<p class="orgstats organization-details current-position">
Privately Held; 1-10 employees;
Medical Devices industry
</p>
<p class="period">
<abbr class="dtstart" title="2010-05-01">May 2010</abbr>
&#8211; <abbr class="dtstamp" title="2014-10-22">Present</abbr>
<span class="duration"><span class="value-title" title="P4Y6M"> </span>(4 years 6 months)</span>
<span class="location">Piscataway, NJ 08854</span>
</p>
<p class=" description current-position">
&#x2022;Spearheaded a medical device startup to develop multiple medical devices (5 Employees).<br>
&#x2022;Product 1: Autonomous venous access device. Projected recurring market: $2B+ (US).<br>
&#x2022;Product 2: Microfluidic point-of-need screening for ACD. Projected recurring market: $2B+ (US).<br>
&#x2022;Developed functional prototypes and validated through human clinical trials.<br>
&#x2022;Developed all financial models, business plans, and product development timelines.
</p>
</div>
</div>
<div>
<div class="position   experience vevent vcard summary-current" style="display:block">
<a class="include" href="#name"></a>
<div class="postitle">
<h3 class="false">
<span class="title">CEO</span>
</h3>
<h4><strong>
<span class="org summary">Beau Ridge Pharmaceuticals</span>
</strong></strong>
</h4>
</div>
<p class="orgstats organization-details current-position">
</p>
<p class="period">
<abbr class="dtstart" title="2013-01-01">January 2013</abbr>
&#8211; <abbr class="dtstamp" title="2014-10-22">Present</abbr>
<span class="duration"><span class="value-title" title="P1Y10M"> </span>(1 year 10 months)</span>
<span class="location">Greater New York City Area</span>
</p>
</div>
</div>
<div>
<div class="position   experience vevent vcard summary-current" style="display:block">
<a class="include" href="#name"></a>
<div class="postitle">
<h3 class="false">
<span class="title">Director of Business Development</span>
</h3>
<h4><strong>
<a class="company-profile-public" href="/company/rutgers-university?trk=ppro_cprof"><span class="org summary">Rutgers CIVET</span></a>
</strong></strong>
</h4>
</div>
<p class="orgstats organization-details current-position">
Educational Institution; 10,001+ employees;
Higher Education industry
</p>
<p class="period">
<abbr class="dtstart" title="2010-05-01">May 2010</abbr>
&#8211; <abbr class="dtstamp" title="2014-10-22">Present</abbr>
<span class="duration"><span class="value-title" title="P4Y6M"> </span>(4 years 6 months)</span>
<span class="location">Piscataway, NJ 08854</span>
</p>
<p class=" description current-position">
&#x2022;Lead team to restructure the medical device commercialization and CRO work at Rutgers University.<br>
&#x2022;Established industrial research contracts with large pharmaceutical and cosmetic companies ($2M+).<br>
&#x2022;Planned and managed client facing work with 100% timely completion of major milestones.<br>
&#x2022;Authored business plans and financial models for 20+ Rutgers-Based startups.
</p>
</div>
</div>
<div>
<div class="position   experience vevent vcard summary-current" style="display:block">
<a class="include" href="#name"></a>
<div class="postitle">
<h3 class="false">
<span class="title">Associate Research Professor</span>
</h3>
<h4><strong>
<a class="company-profile-public" href="/company/rutgers-university?trk=ppro_cprof"><span class="org summary">Rutgers University</span></a>
</strong></strong>
</h4>
</div>
<p class="orgstats organization-details current-position">
Educational Institution; 10,001+ employees;
Higher Education industry
</p>
<p class="period">
<abbr class="dtstart" title="2010-01-01">January 2010</abbr>
&#8211; <abbr class="dtstamp" title="2014-10-22">Present</abbr>
<span class="duration"><span class="value-title" title="P4Y10M"> </span>(4 years 10 months)</span>
<span class="location">Piscataway NJ</span>
</p>
<p class=" description current-position">
&#x2022;Project 1: Development of physiologically relevant microfluidics systems for toxicity assessment.<br>
&#x2022;Project 2: Development of metabolic conditioning and cell therapies for the treatment of liver failure.<br>
&#x2022;Project 3: Development of Stem cell based therapies for the treatment of TBI, and spinal cord injury.
</p>
</div>
</div>
<div>
<div class="position   experience vevent vcard summary-current" style="display:block">
<a class="include" href="#name"></a>
<div class="postitle">
<h3 class="false">
<span class="title">Adjunct Faculty</span>
</h3>
<h4><strong>
<a class="company-profile-public" href="/company/harvard-medical-school?trk=ppro_cprof"><span class="org summary">Harvard Medical School</span></a>
</strong></strong>
</h4>
</div>
<p class="orgstats organization-details current-position">
Educational Institution; 10,001+ employees;
Higher Education industry
</p>
<p class="period">
<abbr class="dtstart" title="2010-05-01">May 2010</abbr>
&#8211; <abbr class="dtstamp" title="2014-10-22">Present</abbr>
<span class="duration"><span class="value-title" title="P4Y6M"> </span>(4 years 6 months)</span>
<span class="location">Greater Boston Area</span>
</p>
<p class=" description current-position">
&#x2022;Project 1: MEMs based diagnostics.<br>
&#x2022;Project 2: Bioartificial liver development.<br>
&#x2022;Project 3: Decellularized liver scaffolds as tissue engineering therapies.
</p>
</div>
</div>
<div>
<div class="position   experience vevent vcard summary-past" style="display:block">
<a class="include" href="#name"></a>
<div class="postitle">
<h3 class="false">
<span class="title">COO</span>
</h3>
<h4><strong>
<span class="org summary">Hurel Corporation</span>
</strong></strong>
</h4>
</div>
<p class="orgstats organization-details past-position">
</p>
<p class="period">
<abbr class="dtstart" title="2008-10-01">October 2008</abbr>
&#8211; <abbr class="dtend" title="2010-05-01">May 2010</abbr> <span class="duration"><span class="value-title" title="P1Y8M"> </span>(1 year 8 months)</span>
<span class="location">Kennilworth NJ</span>
</p>
</div>
</div>
<div>
<div class="position   experience vevent vcard summary-past" style="display:block">
<a class="include" href="#name"></a>
<div class="postitle">
<h3 class="false">
<span class="title">Senior Research Chemical Engineer</span>
</h3>
<h4><strong>
<a class="company-profile-public" href="/company/merck?trk=ppro_cprof"><span class="org summary">Merck</span></a>
</strong></strong>
</h4>
</div>
<p class="orgstats organization-details past-position">
Public Company; 10,001+ employees; MRK;
Pharmaceuticals industry
</p>
<p class="period">
<abbr class="dtstart" title="2006-11-01">November 2006</abbr>
&#8211; <abbr class="dtend" title="2008-10-01">October 2008</abbr> <span class="duration"><span class="value-title" title="P2Y"> </span>(2 years)</span>
<span class="location">West Point, PA</span>
</p>
<p class=" description past-position">
Operations <br>
&#x2022;Developed combined project complexity and resource allocation model, focused on reducing lead-time, reducing scale-up cost, integrating clinical and commercial functions throughout the development process, setting expectations for senior management reviews, and aligning strategy with execution. <br>
&#x2022;Led a cross-divisional team to develop new computational tools to reduce intermediate scale-up and validation steps for compounds. <br>
<br>
Product Development<br>
&#x2022;Led early formulation and process development for a variety of solid dosage and liquid filled capsule formulations for multiple franchises including HCV, Oncology, and the Merck-Schering Plough JV.<br>
&#x2022;Implemented FDA Quality by Design standards for five compounds, establishing the process for future solid dosage formulation and transition to scale-up.<br>
&#x2022;Extensive experience in solid dosage formulation, spray drying amorphous compounds, and hot-melt extrusion.
</p>
</div>
</div>
</div>
</div>
</div>
<div class="section" id="profile-certifications" style="display:block">
<div class="header">
<h2>Tim Maguire's Certifications
</h2>
</div>
<div class="content">
<ul class="certifications documents">
<li class="certification first">
<h3>
2015 Level I CFA Candidate
</h3>
<ul class="specifics"><li class="fn org">CFA Institute</li>
</ul>
</li>
</ul>
</div>
</div>
<div class="section subsection-reorder summary-education" id="profile-education" style="display:block">
<div class="header">
<h2>
Tim Maguire's Education
</h2>
</div>
<div class="content vcalendar">
<div>
<div class="position  first education vevent vcard" id="1779179">
<h3 class="summary fn org">
<a href="https://www.linkedin.com/edu/rutgers-the-state-university-of-new-jersey-new-brunswick-18874">Rutgers, The State University of New Jersey-New Brunswick</a>
</h3>
<h4 class="details-education">
<span class="degree">PhD</span>,
<span class="major">
BioMedical Engineering </span>
</h4>
<p class="period">
<abbr class="dtstart" title="2001-01-01">2001</abbr> &#8211; <abbr class="dtend" title="2006-12-31">2006</abbr>
</p>
<p class=" desc details-education">
</p>
<p class="desc details-education" name="activities"><em>Activities and Societies:</em>
President of the Biomedical Engineering Student Society (BESS) </p>
</div>
<div class="position  education vevent vcard" id="2827168">
<h3 class="summary fn org">
<a href="https://www.linkedin.com/edu/rutgers-university-new-brunswick-18874">Rutgers University-New Brunswick</a>
</h3>
<h4 class="details-education">
<span class="degree">BS</span>,
<span class="major">
Chemical Engineering </span>
</h4>
<p class="period">
<abbr class="dtstart" title="1997-01-01">1997</abbr> &#8211; <abbr class="dtend" title="2001-12-31">2001</abbr>
</p>
<p class=" desc details-education">
</p>
<p class="desc details-education" name="activities"><em>Activities and Societies:</em>
Chemical Engineering Honor Society </p>
</div>
</div>
</div>
</div>
<div class="section" id="profile-patents" style="display:block">
<div class="header">
<h2> Tim Maguire's Patents
</h2>
</div>
<div class="content">
<ul class="patents documents">
<li class="patent vevent vcard first">
<h3>
<a href="/redir/redirect?url=https%3A%2F%2Fwww%2Egoogle%2Ecom%2Fpatents%2FWO2010056538A1%3Fcl%3Den%26dq%3Dmaguire%2Byarmush%26hl%3Den%26sa%3DX%26ei%3Dr_QMUoeMBffi4AOMh4HYBQ%26ved%3D0CDsQ6AEwAQ&amp;urlhash=GlTt" target="_blank" title="New window will open" name="patentsite">
An automated vessel puncture device using three-dimensional(3d) near infrared (nir) imaging and a robotically driven needle
</a>
</h3>
<ul class="specifics">
<li><span class="fn org">United States</span> Patent Application US2009/062550</li> <li>Filed <span class="dtstart">October 29, 2009</span></li>
</ul>
<div class="attribution"> Inventors:
<a href="http://www.linkedin.com/pub/tim-maguire/1/9b8/238">Tim Maguire</a>
</div>
<div class="summary">
<p class=" description">
The present invention is directed to an automated vessel puncture device, methods of mapping three-dimensional views of subcutaneous vessels and methods for providing simultaneous real-time diagnostic assay.
</p>
<script id="control-http-12248-exec-744691-1" type="linkedin/control" class="li-control">LI.i18n.register('ShowMore-see-more','more');LI.i18n.register('ShowMore-see-less','less');LI.i18n.register('ShowMore-see-more-long','Show more');LI.i18n.register('ShowMore-see-less-long','Show less');LI.Controls.addControl('control-http-12248-exec-744691-1','ShowMore',{charCount:400});</script>
</div>
</li>
<li class="patent vevent vcard">
<h3>
<a href="/redir/redirect?url=https%3A%2F%2Fwww%2Egoogle%2Ecom%2Fpatents%2FWO2006122147A3%3Fcl%3Den%26dq%3Dmaguire%2Byarmush%26hl%3Den%26sa%3DX%26ei%3Dr_QMUoeMBffi4AOMh4HYBQ%26ved%3D0CDQQ6AEwAA&amp;urlhash=fIk0" target="_blank" title="New window will open" name="patentsite">
Alginate poly-l-lysine encapsulation as a technology for controlled differentiation of embryonic stem cells
</a>
</h3>
<ul class="specifics">
<li><span class="fn org">United States</span> Patent US2006/017968</li> <li>Issued <span class="dtstart">May 9, 2006</span></li>
</ul>
<div class="attribution"> Inventors:
<a href="http://www.linkedin.com/pub/tim-maguire/1/9b8/238">Tim Maguire</a>
</div>
<div class="summary">
<p class=" description">
Alginate polyelectrolyte encapsulation is used for the controlled differentiation of embryonic stem cells. An isolated cell population is provided. The cell population includes a single cell suspension of ES cells encapsulated within an alginate polyelectrolyte microenvironment. The encapsulated ES cells are capable of differentiating within said microenvironment into hepatocyte lineage cells in the absence of embryoid body intermediates or growth factor supplementation.
</p>
<script id="control-http-12248-exec-744692-2" type="linkedin/control" class="li-control">LI.Controls.addControl('control-http-12248-exec-744692-2','ShowMore',{charCount:400});</script>
</div>
</li>
<li class="patent vevent vcard">
<h3>
<a href="/redir/redirect?url=https%3A%2F%2Fwww%2Egoogle%2Ecom%2Fpatents%2FWO2013025519A1%3Fcl%3Den%26dq%3Dmaguire%2Byarmush%26hl%3Den%26sa%3DX%26ei%3Dr_QMUoeMBffi4AOMh4HYBQ%26ved%3D0CEkQ6AEwAw&amp;urlhash=XsjW" target="_blank" title="New window will open" name="patentsite">
High throughput sensitization detection devices and methods
</a>
</h3>
<ul class="specifics">
<li><span class="fn org">United States</span> Patent US2012/050375</li> <li>Issued <span class="dtstart">August 10, 2012</span></li>
</ul>
<div class="attribution"> Inventors:
<a href="http://www.linkedin.com/pub/tim-maguire/1/9b8/238">Tim Maguire</a>
</div>
<div class="summary">
<p class=" description">
This invention discloses devices and methods for high throughput skin sensitization detection. The devices comprise a microfibricated chamber comprising a region having one or more input channels and an outlet, and a face suitable for mounting a skin tissue and in fluidic communication with the region. The devices can be used in the methods for determining a prognosis of sensitization in an animal subject and identifying compounds that do not cause sensitization and thus are suitable for preparing cosmetic compositions.
</p>
<script id="control-http-12248-exec-744692-3" type="linkedin/control" class="li-control">LI.Controls.addControl('control-http-12248-exec-744692-3','ShowMore',{charCount:400});</script>
</div>
</li>
</ul>
</div>
</div>
<div class="section" id="profile-publications" style="display:block">
<div class="header">
<h2>Tim Maguire's Publications
</h2>
</div>
<div class="content">
<ul class="publications documents">
<li class="publication vevent vcard first">
<h3>
<a href="/redir/redirect?url=http%3A%2F%2Fwww%2Encbi%2Enlm%2Enih%2Egov%2Fpubmed%2F22571482&amp;urlhash=QDrl" target="_blank" title="New window will open" name="publicationsite" class="url">
<cite>Physiologically Based Pharmacokinetic Models: Integration of In Silico Approaches with Micro Cell Culture Analogues.</cite>
</a>
</h3>
<ul class="specifics">
<li>Current Drug Metabolism</li><li class="dtstart">May 8, 2012</li>
</ul>
<div class="summary">
<p class=" &#39;&#39;">
There is a large emphasis within the pharmaceutical industry to provide tools that will allow early research and development groups to better predict dose ranges for and metabolic responses of candidate molecules in a high throughput manner, prior to entering clinical trials. These tools incorporate approaches ranging from PBPK, QSAR, and molecular dynamics simulations in the in silico realm, to micro cell culture analogue (CCAs)s in the in vitro realm. This paper will serve to review these areas of high throughput predictive research, and highlight hurdles and potential solutions. In particular we will focus on CCAs, as their incorporation with PBPK modeling has the potential to replace animal testing, with a more predictive assay that can combine multiple organ analogs on one microfluidic platform in physiologically correct volume ratios. While several advantages arise from the current embodiments of CCAS in a microfluidic format that can be exploited for realistic simulations of drug absorption, metabolism and action, we explore some of the concerns with these systems, and provide a potential path forward to realizing animal-free solutions. Furthermore we envision that, together with theoretical modeling, CCAs may produce reliable predictions of the efficacy of newly developed drugs.
</p>
<script id="control-http-12248-exec-744693-4" type="linkedin/control" class="li-control">LI.Controls.addControl('control-http-12248-exec-744693-4','ShowMore',{charCount:400});</script>
</div>
</li>
<li class="publication vevent vcard">
<h3>
<a href="/redir/redirect?url=http%3A%2F%2Fwww%2Encbi%2Enlm%2Enih%2Egov%2Fpubmed%2F22432625&amp;urlhash=8Y0P" target="_blank" title="New window will open" name="publicationsite" class="url">
<cite>Tissue engineering and regenerative medicine: history, progress, and challenges.</cite>
</a>
</h3>
<ul class="specifics">
<li>Annual Review of Chemical and Biochemical Engineering</li><li class="dtstart">2011</li>
</ul>
<div class="summary">
<p class=" &#39;&#39;">
The past three decades have seen the emergence of an endeavor called tissue engineering and regenerative medicine in which scientists, engineers, and physicians apply tools from a variety of fields to construct biological substitutes that can mimic tissues for diagnostic and research purposes and can replace (or help regenerate) diseased and injured tissues. A significant portion of this effort has been translated to actual therapies, especially in the areas of skin replacement and, to a lesser extent, cartilage repair. A good amount of thoughtful work has also yielded prototypes of other tissue substitutes such as nerve conduits, blood vessels, liver, and even heart. Forward movement to clinical product, however, has been slow. Another offshoot of these efforts has been the incorporation of some new exciting technologies (e.g., microfabrication, 3D printing) that may enable future breakthroughs. In this review we highlight the modest beginnings of the field and then describe three application examples that are in various stages of development, ranging from relatively mature (skin) to ongoing proof-of-concept (cartilage) to early stage (liver). We then discuss some of the major issues that limit the development of complex tissues, some of which are fundamentals-based, whereas others stem from the needs of the end users.
</p>
<script id="control-http-12248-exec-744693-5" type="linkedin/control" class="li-control">LI.Controls.addControl('control-http-12248-exec-744693-5','ShowMore',{charCount:400});</script>
</div>
</li>
<li class="publication vevent vcard">
<h3>
<a href="/redir/redirect?url=http%3A%2F%2Fwww%2Encbi%2Enlm%2Enih%2Egov%2Fpubmed%2F20166997&amp;urlhash=AGqh" target="_blank" title="New window will open" name="publicationsite" class="url">
<cite>Design and application of microfluidic systems for in vitro pharmacokinetic evaluation of drug candidates.</cite>
</a>
</h3>
<ul class="specifics">
<li>Current Drug Metabolism</li><li class="dtstart">2009</li>
</ul>
<div class="summary">
<p class=" &#39;&#39;">
One of the fundamental challenges facing the development of new chemical entities within the pharmaceutical industry is the extrapolation of key in vivo parameters from in vitro cell culture assays and animal studies. Development of microscale devices and screening assays incorporating primary human cells can potentially provide better, faster and more efficient prediction of in vivo toxicity and clinical drug performance. With this goal in mind, large strides have been made in the area of microfluidics to provide in vitro surrogates that are designed to mimic the physiological architecture and dynamics. More recent advancements have been made in the development of in vitro analogues to physiologically-based pharmacokinetic (PBPK) models - a mathematical model that represents the body as interconnected compartments specific for a particular organ. In this review we highlight recent advancements in human hepatocyte microscale culture, and describe the next generation of integrated devices, whose potential allows for the high throughput assessment of drug metabolism, distribution and pharmacokinetics.
</p>
<script id="control-http-12248-exec-744693-6" type="linkedin/control" class="li-control">LI.Controls.addControl('control-http-12248-exec-744693-6','ShowMore',{charCount:400});</script>
</div>
</li>
<li class="publication vevent vcard">
<h3>
<a href="/redir/redirect?url=http%3A%2F%2Fwww%2Encbi%2Enlm%2Enih%2Egov%2Fpubmed%2F19925779&amp;urlhash=yFu1" target="_blank" title="New window will open" name="publicationsite" class="url">
<cite>A microfluidic hepatic coculture platform for cell-based drug metabolism studies.</cite>
</a>
</h3>
<ul class="specifics">
<li>Biochemical Pharmacology</li><li class="dtstart">April 1, 2010</li>
</ul>
<div class="summary">
<p class=" &#39;&#39;">
Within the global pharmaceutical and biotech industries, there is significant interest in identifying in vitro screening systems that are more human-relevant-i.e., that offer greater utility in predicting subcellular and cellular physiological responses in humans in vivo-and that thereby allow investigators to reduce the incidence of costly late-stage failures during pharmaceutical clinical trials, as well as to reduce the use of animals in drug testing. Currently incumbent in vitro screening methods, such as culturing human hepatocytes in suspension, while useful, are limited by a lack of long term cellular function. In order to address this limitation, we have established an integrated, microfluidic, in vitro platform that combines the patented HmuREL((R)) microdevice with a hepatic coculture system. In the present report, we use this platform to study clearance and metabolite generation of a battery of molecular entities. The results show that the flow-based coculture system is capable of clearing, with improved resolution and predictive value, compounds with high, medium, and low clearance values. In addition, when coculture is coupled with flow, higher metabolite production rates are obtained than in static systems.
</p>
<script id="control-http-12248-exec-744694-7" type="linkedin/control" class="li-control">LI.Controls.addControl('control-http-12248-exec-744694-7','ShowMore',{charCount:400});</script>
</div>
</li>
<li class="publication vevent vcard">
<h3>
<a href="/redir/redirect?url=http%3A%2F%2Fwww%2Encbi%2Enlm%2Enih%2Egov%2Fpubmed%2F19463793&amp;urlhash=1kg_" target="_blank" title="New window will open" name="publicationsite" class="url">
<cite>Evaluation of a microfluidic based cell culture platform with primary human hepatocytes for the prediction of hepatic clearance in human.</cite>
</a>
</h3>
<ul class="specifics">
<li>Biochem Pharmacol.</li><li class="dtstart">September 2009</li>
</ul>
</li>
<li class="publication vevent vcard">
<h3>
<a href="/redir/redirect?url=http%3A%2F%2Fonlinelibrary%2Ewiley%2Ecom%2Fdoi%2F10%2E1111%2Fj%2E1600-6143%2E2012%2E04288%2Ex%2Fabstract%3Bjsessionid%3D88F0988C780CC087EE3ECB12D63FB78C%2Ed04t02&amp;urlhash=37dg" target="_blank" title="New window will open" name="publicationsite" class="url">
<cite>Liver Defatting: An Alternative Approach to Enable Steatotic Liver Transplantation</cite>
</a>
</h3>
<ul class="specifics">
<li>American Journal of Transplantation</li><li class="dtstart">October 11, 2012</li>
</ul>
<div class="summary">
<p class=" &#39;&#39;">
Macrovesicular steatosis in greater than 30% of hepatocytes is a significant risk factor for primary graft nonfunction due to increased sensitivity to ischemia reperfusion (I/R) injury. The growing prevalence of hepatic steatosis due to the obesity epidemic, in conjunction with an aging population, may negatively impact the availability of suitable deceased liver donors. Some have suggested that metabolic interventions could decrease the fat content of liver grafts prior to transplantation. This concept has been successfully tested through nutritional supplementation in a few living donors. Utilization of deceased donor livers, however, requires defatting of explanted organs. Animal studies suggest that this can be accomplished by ex vivo warm perfusion in a time scale of a few hours. We estimate that this approach could significantly boost the size of the donor pool by increasing the utilization of steatotic livers. Here we review current knowledge on the mechanisms whereby excessive lipid storage and macrosteatosis exacerbate hepatic I/R injury, and possible approaches to address this problem, including ex vivo perfusion methods as well as metabolically induced defatting. We also discuss the challenges ahead that need to be addressed for clinical implementation.
</p>
<script id="control-http-12248-exec-744694-8" type="linkedin/control" class="li-control">LI.Controls.addControl('control-http-12248-exec-744694-8','ShowMore',{charCount:400});</script>
</div>
</li>
<li class="publication vevent vcard">
<h3>
<cite>Elevated Sensitivity of Macrosteatotic Hepatocytes to Hypoxia-Reoxygenation Stress Is Reversed by a Novel Defatting Protocol</cite>
</h3>
<ul class="specifics">
<li>Liver Transplantation (accepted for publication)</li>
</ul>
<div class="summary">
<p class=" &#39;&#39;">
Macrosteatotic livers exhibit elevated intrahepatic triglyceride (TG) content in the form of large lipid droplets (LDs), reduced ATP, and elevated reactive oxygen species (ROS), contributing to their elevated sensitivity to ischemia-reperfusion injury during transplantation. Decreasing macrosteatosis in living donors through dieting has been shown to improve transplantation outcome. <br>
Accomplishing the same feat in deceased donor grafts would require ex-vivo exposure to potent defatting agents. <br>
<br>
Herein, we used a rat hepatocyte culture system exhibiting macrosteatotic LD morphology, elevated TG levels, and elevated sensitivity to hypoxia and reoxygenation (H/R), to test for such agents and ameliorate H/R sensitivity. Macrosteatotic hepatocyte preconditioning for 48h with a <br>
defatting cocktail, previously developed to promote TG catabolism, reduced the number of macrosteatotic LDs and intracellular TG levels by 82% and 27%, respectively, but did not ameliorate sensitivity to H/R. <br>
L-carnitine supplementation to this cocktail, together with hyperoxic exposure, yielded a similar reduction in macrosteatotic LD numbers, and to a 57% reduction in intrahepatic TG storage, likely by increasing the supply of acetyl-CoA to mitochondria, as indicated by a 70% increase in ketone body secretion. <br>
Furthermore, this treatment reduced ROS levels by 32%, increased ATP levels by 27%, nearing ATP levels of lean controls, and completely abolished H/R sensitivity as indicated by ~85% viability post H/R and return of cytosolic lactate dehydrogenase release down to levels seen in lean controls. <br>
Cultures maintained for 48h post H/R were ~83% viable and exhibited superior urea secretion and bile canalicular transport compared to untreated macrosteatotic cultures. These findings show that the elevated sensitivity of macrosteatotic hepatocytes to H/R can be overcome by defatting agents, suggesting a possible route for the recovery of discarded macrosteatotic grafts.
</p>
<script id="control-http-12248-exec-744694-9" type="linkedin/control" class="li-control">LI.Controls.addControl('control-http-12248-exec-744694-9','ShowMore',{charCount:400});</script>
</div>
</li>
</ul>
</div>
</div>
<div class="section" id="profile-skills" style="display:block">
<div class="header">
<h2>Tim Maguire's Skills &amp; Expertise
</h2>
</div>
<div class="content">
<ol class="skills" id="skills-list">
<li class="competency show-bean  ">
<span class="jellybean">
Biotechnology
</span>
</li>
<li class="competency show-bean  ">
<span class="jellybean">
Biomedical Engineering
</span>
</li>
<li class="competency show-bean  ">
<span class="jellybean">
Medical Devices
</span>
</li>
<li class="competency show-bean  ">
<span class="jellybean">
R&amp;D
</span>
</li>
<li class="competency show-bean  ">
<span class="jellybean">
Cell Biology
</span>
</li>
<li class="competency show-bean  ">
<span class="jellybean">
Tissue Engineering
</span>
</li>
<li class="competency show-bean  ">
<span class="jellybean">
Start-ups
</span>
</li>
<li class="competency show-bean  ">
<span class="jellybean">
Commercialization
</span>
</li>
<li class="competency show-bean  ">
<span class="jellybean">
Business Strategy
</span>
</li>
<li class="competency show-bean  ">
<span class="jellybean">
Pharmaceutical Industry
</span>
</li>
<li class="competency show-bean  ">
<span class="jellybean">
Drug Delivery
</span>
</li>
<li class="competency show-bean  ">
<span class="jellybean">
Bioinformatics
</span>
</li>
<li class="competency show-bean  ">
<span class="jellybean">
Lifesciences
</span>
</li>
<li class="competency show-bean  ">
<span class="jellybean">
Entrepreneurship
</span>
</li>
<li class="competency show-bean  ">
<span class="jellybean">
Strategy
</span>
</li>
<li class="competency show-bean  ">
<span class="jellybean">
FDA
</span>
</li>
<li class="competency show-bean  ">
<span class="jellybean">
Clinical Research
</span>
</li>
<li class="competency show-bean  ">
<span class="jellybean">
Operations Management
</span>
</li>
<li class="competency show-bean  ">
<span class="jellybean">
Biomaterials
</span>
</li>
<li class="competency show-bean  ">
<span class="jellybean">
Cell Culture
</span>
</li>
<li class="competency show-bean  extra-skill">
<span class="jellybean">
Project Management
</span>
</li>
<li class="competency show-bean  extra-skill">
<span class="jellybean">
Mobile Applications
</span>
</li>
<li class="competency show-bean  extra-skill">
<span class="jellybean">
Clinical Development
</span>
</li>
<li class="competency show-bean  extra-skill">
<span class="jellybean">
Stem Cells
</span>
</li>
<li class="competency show-bean  extra-skill">
<span class="jellybean">
Biochemistry
</span>
</li>
<li class="competency show-bean  extra-skill">
<span class="jellybean">
Neuroscience
</span>
</li>
<li class="competency show-bean  extra-skill">
<span class="jellybean">
Clinical Trials
</span>
</li>
<li class="competency show-bean  extra-skill">
<span class="jellybean">
Technology Transfer
</span>
</li>
<li class="competency show-bean  extra-skill">
<span class="jellybean">
Financial Analysis
</span>
</li>
<li class="competency show-bean  extra-skill">
<span class="jellybean">
Validation
</span>
</li>
<li class="competency show-bean  extra-skill">
<span class="jellybean">
Molecular Biology
</span>
</li>
<li class="competency show-bean  extra-skill">
<span class="jellybean">
Product Development
</span>
</li>
<li class="competency show-bean  extra-skill">
<span class="jellybean">
Drug Discovery
</span>
</li>
<li class="competency show-bean  extra-skill">
<span class="jellybean">
Biopharmaceuticals
</span>
</li>
<li class="competency show-bean  extra-skill">
<span class="jellybean">
PCR
</span>
</li>
<li class="competency show-bean  extra-skill">
<span class="jellybean">
Assay Development
</span>
</li>
<li class="competency show-bean  extra-skill">
<span class="jellybean">
Business Development
</span>
</li>
<li class="competency show-bean  extra-skill">
<span class="jellybean">
Drug Development
</span>
</li>
<li class="competency show-bean  extra-skill">
<span class="jellybean">
Pharmacology
</span>
</li>
<li class="competency show-bean  extra-skill">
<span class="jellybean">
Analytics
</span>
</li>
<li class="competency show-bean  extra-skill">
<span class="jellybean">
Nanotechnology
</span>
</li>
<li class="competency show-bean  extra-skill">
<span class="jellybean">
Financial Modeling
</span>
</li>
<li class="competency show-bean  extra-skill">
<span class="jellybean">
Immunology
</span>
</li>
<li class="competency show-bean  extra-skill">
<span class="jellybean">
jQuery
</span>
</li>
<li class="competency show-bean  extra-skill">
<span class="jellybean">
Python
</span>
</li>
<li class="competency show-bean  extra-skill">
<span class="jellybean">
SPSS
</span>
</li>
</ol>
<p class="see-more-less">
<a href="#">
<span class="more-text">View All (46) Skills</span>
<span class="less-text">View Fewer Skills</span>
</a>
</p>
<script id="control-http-12248-exec-744698-10" type="linkedin/control" class="li-control">LI.Controls.addControl('control-http-12248-exec-744698-10','ToggleClass',{classname:'view-all-skills',on:'#profile-skills'});</script>
</div>
</div>
<div class="section" id="profile-additional" style="display:block">
<div class="header">
<h2>Tim Maguire's Additional Information
</h2>
</div>
<div class="content">
<dl>
<dt class="websites" style="display:block">Websites:</dt>
<dd class="websites" style="display:block">
<ul>
<li class="website">
<a href="/redir/redirect?url=http%3A%2F%2Fvasculogic%2Ecom%2F&amp;urlhash=r-f1" target="_blank" title="New window will open">
Company Website
</a>
</li>
<li class="website">
<a href="/redir/redirect?url=http%3A%2F%2Fscienceunveiled%2Eblogspot%2Ecom%2F&amp;urlhash=v1ij" target="_blank" title="New window will open">
Personal Website
</a>
</li>
<li class="website">
<a href="/redir/redirect?url=http%3A%2F%2Firtfoundation%2Eorg%2F&amp;urlhash=_rpv" target="_blank" title="New window will open">
My Non-Profit Company
</a>
</li>
</ul>
</dd>
<dt class="interests" style="display:block">Interests:</dt>
<dd class="interests" id="interests" style="display:block">
<p class="">
Playing Jazz Music, Hiking </p>
</dd>
<dt class="pubgroups" style="display:block">Groups and Associations:</dt>
<dd class="pubgroups" id="pubgroups" style="display:block">
<p class="null">
AEMB, BMES
Omega Chi Epsilon, 2001 </p>
<ul class="groups">
<li class="affiliation vcard">
<a class="group-logo" href="/groups?gid=52909" tracking="fulpro_grplogo"> <img src="http://m.c.lnkd.licdn.com/media/p/3/000/004/1b3/328a289.png" width="60" height="30" alt="Angel Investor Group logo"/>
</a>
<div class="group-data">
<a href="/groups?gid=52909" tracking="fulpro_grplogo"><strong class="fn org">Angel Investor Group</strong></a>
</div>
</li>
<li class="affiliation vcard">
<a class="group-logo" href="/groups?gid=38728" tracking="fulpro_grplogo"> <img src="http://m.c.lnkd.licdn.com/media/p/4/000/162/167/34bbe2d.png" width="60" height="30" alt="CFA Program Candidates logo"/>
</a>
<div class="group-data">
<a href="/groups?gid=38728" tracking="fulpro_grplogo"><strong class="fn org">CFA Program Candidates</strong></a>
</div>
</li>
<li class="affiliation vcard">
<a class="group-logo" href="/groups?gid=40103" tracking="fulpro_grplogo"> <img src="http://m.c.lnkd.licdn.com/media/p/3/000/084/39a/13707d1.png" width="60" height="30" alt="Consultants Network logo"/>
</a>
<div class="group-data">
<a href="/groups?gid=40103" tracking="fulpro_grplogo"><strong class="fn org">Consultants Network</strong></a>
</div>
</li>
<li class="affiliation vcard">
<a class="group-logo" href="/groups/DOC-New-York-Chapter-PhDs-4636367" tracking="fulpro_grplogo"> <img src="/img/icon/group/icon_group_60x30_v2.png" width="60" height="30" alt="DOC New York Chapter, PhDs and MDs in Industry logo"/>
</a>
<div class="group-data">
<a href="/groups/DOC-New-York-Chapter-PhDs-4636367" tracking="fulpro_grplogo"><strong class="fn org">DOC New York Chapter, PhDs and MDs in Industry</strong></a>
</div>
</li>
<li class="affiliation vcard">
<a class="group-logo" href="/groups?gid=61789" tracking="fulpro_grplogo"> <img src="http://m.c.lnkd.licdn.com/media/p/2/000/005/232/32254e3.png" width="60" height="30" alt="Electronic Trading Group logo"/>
</a>
<div class="group-data">
<a href="/groups?gid=61789" tracking="fulpro_grplogo"><strong class="fn org">Electronic Trading Group</strong></a>
</div>
</li>
<li class="affiliation vcard">
<a class="group-logo" href="/groups?gid=5090000" tracking="fulpro_grplogo"> <img src="/img/icon/group/icon_group_60x30_v2.png" width="60" height="30" alt="Executive Alliance for Life Science (EALS) logo"/>
</a>
<div class="group-data">
<a href="/groups?gid=5090000" tracking="fulpro_grplogo"><strong class="fn org">Executive Alliance for Life Science (EALS)</strong></a>
</div>
</li>
<li class="affiliation vcard">
<a class="group-logo" href="/groups/FiercePharma-Network-Pharmaceutical-Professionals-5042642" tracking="fulpro_grplogo"> <img src="http://m.c.lnkd.licdn.com/media/p/4/005/04b/1c2/095babc.png" width="60" height="30" alt="FiercePharma: A Network of Pharmaceutical Professionals logo"/>
</a>
<div class="group-data">
<a href="/groups/FiercePharma-Network-Pharmaceutical-Professionals-5042642" tracking="fulpro_grplogo"><strong class="fn org">FiercePharma: A Network of Pharmaceutical Professionals</strong></a>
</div>
</li>
<li class="affiliation vcard">
<a class="group-logo" href="/groups/Harvard-Business-Review-3044917" tracking="fulpro_grplogo"> <img src="http://m.c.lnkd.licdn.com/media/p/4/005/02d/215/14485fd.png" width="60" height="30" alt="Harvard Business Review logo"/>
</a>
<div class="group-data">
<a href="/groups/Harvard-Business-Review-3044917" tracking="fulpro_grplogo"><strong class="fn org">Harvard Business Review</strong></a>
</div>
</li>
<li class="affiliation vcard">
<a class="group-logo" href="/groups?gid=2015159" tracking="fulpro_grplogo"> <img src="http://m.c.lnkd.licdn.com/media/p/4/000/140/3a7/10393e1.png" width="60" height="30" alt="Harvard Medical School Community Networking Group logo"/>
</a>
<div class="group-data">
<a href="/groups?gid=2015159" tracking="fulpro_grplogo"><strong class="fn org">Harvard Medical School Community Networking Group</strong></a>
</div>
</li>
<li class="affiliation vcard">
<a class="group-logo" href="/groups/IMPACT-Capital-Conference-4999903" tracking="fulpro_grplogo"> <img src="http://m.c.lnkd.licdn.com/media/p/4/005/039/07c/3cc2a41.png" width="60" height="30" alt="IMPACT Capital Conference logo"/>
</a>
<div class="group-data">
<a href="/groups/IMPACT-Capital-Conference-4999903" tracking="fulpro_grplogo"><strong class="fn org">IMPACT Capital Conference</strong></a>
</div>
</li>
<li class="affiliation vcard">
<a class="group-logo" href="/groups?gid=4130465" tracking="fulpro_grplogo"> <img src="http://m.c.lnkd.licdn.com/media/p/3/005/069/165/0a9b001.png" width="60" height="30" alt="LTEN Medical Device and Diagnostics Trainers logo"/>
</a>
<div class="group-data">
<a href="/groups?gid=4130465" tracking="fulpro_grplogo"><strong class="fn org">LTEN Medical Device and Diagnostics Trainers</strong></a>
</div>
</li>
<li class="affiliation vcard">
<a class="group-logo" href="/groups?gid=8154834" tracking="fulpro_grplogo"> <img src="http://m.c.lnkd.licdn.com/media/p/3/005/07f/24d/27429a6.png" width="60" height="30" alt="Mackenzie Stuart Jobs logo"/>
</a>
<div class="group-data">
<a href="/groups?gid=8154834" tracking="fulpro_grplogo"><strong class="fn org">Mackenzie Stuart Jobs</strong></a>
</div>
</li>
<li class="affiliation vcard">
<a class="group-logo" href="/groups/Management-Consulting-Jobs-Powered-IvyExeccom-1816138" tracking="fulpro_grplogo"> <img src="http://m.c.lnkd.licdn.com/media/p/2/000/01d/0e1/19a7a2a.png" width="60" height="30" alt="Management Consulting Jobs - Powered by IvyExec.com logo"/>
</a>
<div class="group-data">
<a href="/groups/Management-Consulting-Jobs-Powered-IvyExeccom-1816138" tracking="fulpro_grplogo"><strong class="fn org">Management Consulting Jobs - Powered by IvyExec.com</strong></a>
</div>
</li>
<li class="affiliation vcard">
<a class="group-logo" href="/groups?gid=909917" tracking="fulpro_grplogo"> <img src="http://m.c.lnkd.licdn.com/media/p/1/005/044/1c8/0a99aa0.png" width="60" height="30" alt="McKinsey Quarterly logo"/>
</a>
<div class="group-data">
<a href="/groups?gid=909917" tracking="fulpro_grplogo"><strong class="fn org">McKinsey Quarterly</strong></a>
</div>
</li>
<li class="affiliation vcard">
<a class="group-logo" href="/groups?gid=78665" tracking="fulpro_grplogo"> <img src="http://m.c.lnkd.licdn.com/media/p/4/000/13a/02a/04af0bf.png" width="60" height="30" alt="Medical Devices Group logo"/>
</a>
<div class="group-data">
<a href="/groups?gid=78665" tracking="fulpro_grplogo"><strong class="fn org">Medical Devices Group</strong></a>
</div>
</li>
<li class="affiliation vcard">
<a class="group-logo" href="/groups?gid=1777425" tracking="fulpro_grplogo"> <img src="/img/icon/group/icon_group_60x30_v2.png" width="60" height="30" alt="Medical Devices Startups logo"/>
</a>
<div class="group-data">
<a href="/groups?gid=1777425" tracking="fulpro_grplogo"><strong class="fn org">Medical Devices Startups</strong></a>
</div>
</li>
<li class="affiliation vcard">
<a class="group-logo" href="/groups?gid=4329333" tracking="fulpro_grplogo"> <img src="http://m.c.lnkd.licdn.com/media/p/4/000/141/3ec/3ab0043.png" width="60" height="30" alt="Medical Devices: New York Tri-State logo"/>
</a>
<div class="group-data">
<a href="/groups?gid=4329333" tracking="fulpro_grplogo"><strong class="fn org">Medical Devices: New York Tri-State</strong></a>
</div>
</li>
<li class="affiliation vcard">
<a class="group-logo" href="/groups?gid=85207" tracking="fulpro_grplogo"> <img src="/img/icon/group/icon_group_60x30_v2.png" width="60" height="30" alt="Merck and Co. Network logo"/>
</a>
<div class="group-data">
<a href="/groups?gid=85207" tracking="fulpro_grplogo"><strong class="fn org">Merck and Co. Network</strong></a>
</div>
</li>
<li class="affiliation vcard">
<a class="group-logo" href="/groups/Mid-Atlantic-Bio-Angels-5173315" tracking="fulpro_grplogo"> <img src="http://m.c.lnkd.licdn.com/media/p/1/005/045/22a/0e64084.png" width="60" height="30" alt="Mid Atlantic Bio Angels logo"/>
</a>
<div class="group-data">
<a href="/groups/Mid-Atlantic-Bio-Angels-5173315" tracking="fulpro_grplogo"><strong class="fn org">Mid Atlantic Bio Angels</strong></a>
</div>
</li>
<li class="affiliation vcard">
<a class="group-logo" href="/groups/MidAtlantic-Diamond-Ventures-MADV-3790301" tracking="fulpro_grplogo"> <img src="http://m.c.lnkd.licdn.com/media/p/2/000/099/23a/015d218.png" width="60" height="30" alt="Mid-Atlantic Diamond Ventures (MADV) logo"/>
</a>
<div class="group-data">
<a href="/groups/MidAtlantic-Diamond-Ventures-MADV-3790301" tracking="fulpro_grplogo"><strong class="fn org">Mid-Atlantic Diamond Ventures (MADV)</strong></a>
</div>
</li>
<li class="affiliation vcard">
<a class="group-logo" href="/groups?gid=4128818" tracking="fulpro_grplogo"> <img src="http://m.c.lnkd.licdn.com/media/p/1/000/0ff/203/1f99e9e.png" width="60" height="30" alt="New Jersey Biotech Professionals logo"/>
</a>
<div class="group-data">
<a href="/groups?gid=4128818" tracking="fulpro_grplogo"><strong class="fn org">New Jersey Biotech Professionals</strong></a>
</div>
</li>
<li class="affiliation vcard">
<a class="group-logo" href="/groups/Precision-Medicine-BigDATA-5180384" tracking="fulpro_grplogo"> <img src="http://m.c.lnkd.licdn.com/media/p/3/005/013/029/13ab425.png" width="60" height="30" alt="Precision Medicine &amp;amp; Big-DATA logo"/>
</a>
<div class="group-data">
<a href="/groups/Precision-Medicine-BigDATA-5180384" tracking="fulpro_grplogo"><strong class="fn org">Precision Medicine &amp; Big-DATA</strong></a>
</div>
</li>
<li class="affiliation vcard">
<a class="group-logo" href="/groups/Private-Equity-M-Venture-Capital-38114" tracking="fulpro_grplogo"> <img src="http://m.c.lnkd.licdn.com/media/p/6/005/07e/3e8/19d1379.png" width="60" height="30" alt="Private Equity, M&amp;amp;A, and Venture Capital Investments logo"/>
</a>
<div class="group-data">
<a href="/groups/Private-Equity-M-Venture-Capital-38114" tracking="fulpro_grplogo"><strong class="fn org">Private Equity, M&amp;A, and Venture Capital Investments</strong></a>
</div>
</li>
<li class="affiliation vcard">
<a class="group-logo" href="/groups?gid=61852" tracking="fulpro_grplogo"> <img src="http://m.c.lnkd.licdn.com/media/p/7/005/00b/171/3ec8aca.png" width="60" height="30" alt="Professionals in the Pharmaceutical and Biotech Industry logo"/>
</a>
<div class="group-data">
<a href="/groups?gid=61852" tracking="fulpro_grplogo"><strong class="fn org">Professionals in the Pharmaceutical and Biotech Industry</strong></a>
</div>
</li>
<li class="affiliation vcard">
<a class="group-logo" href="/groups?gid=1842078" tracking="fulpro_grplogo"> <img src="http://m.c.lnkd.licdn.com/media/p/3/000/01f/00b/02e46e4.png" width="60" height="30" alt="Rancocas Valley Regional High School logo"/>
</a>
<div class="group-data">
<a href="/groups?gid=1842078" tracking="fulpro_grplogo"><strong class="fn org">Rancocas Valley Regional High School</strong></a>
</div>
</li>
<li class="affiliation vcard">
<a class="group-logo" href="/groups/Rutgers-Department-Biomedical-Engineering-Alumni-1788030" tracking="fulpro_grplogo"> <img src="http://m.c.lnkd.licdn.com/media/p/1/000/01f/00b/275d41e.png" width="60" height="30" alt="Rutgers Department of Biomedical Engineering Alumni logo"/>
</a>
<div class="group-data">
<a href="/groups/Rutgers-Department-Biomedical-Engineering-Alumni-1788030" tracking="fulpro_grplogo"><strong class="fn org">Rutgers Department of Biomedical Engineering Alumni</strong></a>
</div>
</li>
<li class="affiliation vcard">
<a class="group-logo" href="/groups/Rutgers-University-85137" tracking="fulpro_grplogo"> <img src="http://m.c.lnkd.licdn.com/media/p/1/000/007/2ad/2e582da.gif" width="60" height="30" alt="Rutgers University logo"/>
</a>
<div class="group-data">
<a href="/groups/Rutgers-University-85137" tracking="fulpro_grplogo"><strong class="fn org">Rutgers University</strong></a>
</div>
</li>
<li class="affiliation vcard">
<a class="group-logo" href="/groups?gid=8190624" tracking="fulpro_grplogo"> <img src="http://m.c.lnkd.licdn.com/media/p/3/005/092/05b/292ebc8.png" width="60" height="30" alt="Rutgers iJOBS logo"/>
</a>
<div class="group-data">
<a href="/groups?gid=8190624" tracking="fulpro_grplogo"><strong class="fn org">Rutgers iJOBS</strong></a>
</div>
</li>
<li class="affiliation vcard">
<a class="group-logo" href="/groups/SYMMYS-Advanced-Risk-Portfolio-Management-3825142" tracking="fulpro_grplogo"> <img src="http://m.c.lnkd.licdn.com/media/p/2/000/0a2/2f6/2c5face.png" width="60" height="30" alt="SYMMYS - Advanced Risk and Portfolio Management logo"/>
</a>
<div class="group-data">
<a href="/groups/SYMMYS-Advanced-Risk-Portfolio-Management-3825142" tracking="fulpro_grplogo"><strong class="fn org">SYMMYS - Advanced Risk and Portfolio Management</strong></a>
</div>
</li>
</ul>
</dd>
<dt class="honors" style="display:block">Honors and Awards:</dt>
<dd class="honors" class="last" style="display:block">
<p class=" &#39;&#39;">
IGERT, Integrated Engineering and Science of Stem Cells<br>
<br>
Biotechnology and Bioengineering Fellowship
</p>
</dd>
</dl>
</div>
</div>
<div class="section" id="profile-contact" style="display:block">
<div class="header">
<h2>Contact Tim for:
</h2>
</div>
<div class="content">
<div class="interested">
<ul>
<li>career opportunities</li>
<li>consulting offers</li>
<li>new ventures</li>
<li>job inquiries</li>
<li>expertise requests</li>
<li>business deals</li>
<li>reference requests</li>
<li>getting back in touch</li>
</ul>
</div>
</div>
</div>
<div class="section view-full-profile">
<div class="header">
<h3>View Tim Maguire&#8217;s full profile to...</h3>
</div>
<div class="content">
<ul>
<li>See who you and <strong>Tim Maguire</strong> know in common</li>
<li>Get introduced to <strong>Tim Maguire</strong></li>
<li>Contact <strong>Tim Maguire</strong> directly</li>
</ul>
<p class="btn">
<a class="action btn-action" href="https://www.linkedin.com/reg/join-pprofile?_ed=0_dHB8G4tKSI1eNkyEd3uBk2dzQE2AkVU1r9kHbXjxPZGWJlD5Jt4ZMf87SacJnJbVJsbATEPh4_pXSAKkE7FxXU3K4xzLc6JUFvuNUlJ3UuS&amp;trk=ppro_viewmore" rel="nofollow">
View Tim's full profile
</a>
</p>
<p class="note">
Not the Tim Maguire you were looking for?
<a href="/pub/dir/?first=Tim&amp;last=Maguire" tracking="ppro_find_others">View more &raquo;</a>
</p>
</div>
</div>
</div>
<div id="extra">
<div class="leo-module mod-action name-search">
<div class="header"><h3>Name Search:</h3></div>
<div class="content">
<p><strong>Search for people you know</strong> from over 300 million professionals already on LinkedIn.</p>
<form name="searchForm" action="/pub/dir/" method="get">
<ul>
<li>
<label for="first">First Name</label>
<script id="control-http-12248-exec-744703-11" type="linkedin/control" class="li-control">LI.Controls.addControl('control-http-12248-exec-744703-11','GhostLabel',{});</script>
<input type="text" name="first" id="first"/>
</li>
<li>
<label for="last">Last Name</label>
<script id="control-http-12248-exec-744703-12" type="linkedin/control" class="li-control">LI.Controls.addControl('control-http-12248-exec-744703-12','GhostLabel',{});</script>
<input type="text" name="last" id="last"/>
</li>
</ul>
<p class="action"><input class="search-go" type="submit" name="search" value="Search"/></p>
<p class="note"> Example:
<strong>
<a href="/pub/dir/?first=Tim&amp;last=Maguire" tracking="ppro_find_others">Tim Maguire</a>
</strong>
</p>
</form>
</div>
</div>
<div class="modules panel">
<div class="leo-module mod-util browsemap">
<div class="header">
<h3><strong>Viewers of this profile also viewed...</strong></h3>
</div>
<div class="content">
<ul>
<li class="with-photo">
<a href="http://www.linkedin.com/pub/eric-novik/2/219/50b?trk=pub-pbmap">
<img src="http://s.c.lnkd.licdn.com/scds/common/u/img/icon/icon_no_photo_40x40.png" class="photo" height="40" width="40" alt="Eric Novik">
</a>
<strong>
<a href="http://www.linkedin.com/pub/eric-novik/2/219/50b?trk=pub-pbmap">Eric Novik</a>
</strong><br>
<span class="headline"></span>
</li>
<li class="with-photo">
<a href="http://www.linkedin.com/pub/nir-nativ/18/59a/87?trk=pub-pbmap">
<img src="http://s.c.lnkd.licdn.com/scds/common/u/img/spacer.gif" data-li-src="http://m.c.lnkd.licdn.com/mpr/mpr/shrink_40_40/p/1/005/04f/12d/124ecd6.jpg" id="img-defer-id-1-4704" class="img-defer-hidden img-defer photo" width="40" height="40" alt="Nir Nativ">
</a>
<strong>
<a href="http://www.linkedin.com/pub/nir-nativ/18/59a/87?trk=pub-pbmap">Nir Nativ</a>
</strong><br>
<span class="headline">R&amp;D Scientist at Ethicon Biosurgery</span>
</li>
<li class="with-photo">
<a href="http://www.linkedin.com/pub/bilal-nadeem/25/93/61?trk=pub-pbmap">
<img src="http://s.c.lnkd.licdn.com/scds/common/u/img/icon/icon_no_photo_40x40.png" class="photo" height="40" width="40" alt="Bilal Nadeem">
</a>
<strong>
<a href="http://www.linkedin.com/pub/bilal-nadeem/25/93/61?trk=pub-pbmap">Bilal Nadeem</a>
</strong><br>
<span class="headline">Senior Engineer at Vasculogic</span>
</li>
<li class="with-photo">
<a href="http://www.linkedin.com/pub/alvin-chen/26/aa4/230?trk=pub-pbmap">
<img src="http://s.c.lnkd.licdn.com/scds/common/u/img/spacer.gif" data-li-src="http://m.c.lnkd.licdn.com/mpr/mpr/shrink_40_40/p/3/005/053/367/12e01e7.jpg" id="img-defer-id-2-4704" class="img-defer-hidden img-defer photo" width="40" height="40" alt="Alvin Chen">
</a>
<strong>
<a href="http://www.linkedin.com/pub/alvin-chen/26/aa4/230?trk=pub-pbmap">Alvin Chen</a>
</strong><br>
<span class="headline">National Institute of Health Graduate...</span>
</li>
<li class="with-photo">
<a href="http://in.linkedin.com/pub/ajay-agrawal/2/436/3b8?trk=pub-pbmap">
<img src="http://s.c.lnkd.licdn.com/scds/common/u/img/spacer.gif" data-li-src="http://m.c.lnkd.licdn.com/mpr/mpr/shrink_40_40/p/8/005/07f/0fc/3c0e125.jpg" id="img-defer-id-3-4704" class="img-defer-hidden img-defer photo" width="40" height="40" alt="Ajay Agrawal">
</a>
<strong>
<a href="http://in.linkedin.com/pub/ajay-agrawal/2/436/3b8?trk=pub-pbmap">Ajay Agrawal</a>
</strong><br>
<span class="headline"></span>
</li>
<li class="with-photo">
<a href="http://www.linkedin.com/pub/kevin-nikitczuk/41/a84/344?trk=pub-pbmap">
<img src="http://s.c.lnkd.licdn.com/scds/common/u/img/spacer.gif" data-li-src="http://m.c.lnkd.licdn.com/mpr/mpr/shrink_40_40/p/2/005/015/04f/203f4eb.jpg" id="img-defer-id-4-4705" class="img-defer-hidden img-defer photo" width="40" height="40" alt="Kevin Nikitczuk">
</a>
<strong>
<a href="http://www.linkedin.com/pub/kevin-nikitczuk/41/a84/344?trk=pub-pbmap">Kevin Nikitczuk</a>
</strong><br>
<span class="headline">Global Incubator at L&#39;Oral</span>
</li>
<li class="with-photo">
<a href="http://www.linkedin.com/pub/sagar-singh/4/b8/723?trk=pub-pbmap">
<img src="http://s.c.lnkd.licdn.com/scds/common/u/img/icon/icon_no_photo_40x40.png" class="photo" height="40" width="40" alt="Sagar Singh">
</a>
<strong>
<a href="http://www.linkedin.com/pub/sagar-singh/4/b8/723?trk=pub-pbmap">Sagar Singh</a>
</strong><br>
<span class="headline">Ph.D Candidate at Rutgers University</span>
</li>
<li class="with-photo">
<a href="http://www.linkedin.com/pub/jason-nikitczuk-phd/97/834/455?trk=pub-pbmap">
<img src="http://s.c.lnkd.licdn.com/scds/common/u/img/spacer.gif" data-li-src="http://m.c.lnkd.licdn.com/mpr/mpr/shrink_40_40/p/4/005/062/3fe/1be6181.jpg" id="img-defer-id-5-4705" class="img-defer-hidden img-defer photo" width="40" height="40" alt="Jason Nikitczuk, PhD">
</a>
<strong>
<a href="http://www.linkedin.com/pub/jason-nikitczuk-phd/97/834/455?trk=pub-pbmap">Jason Nikitczuk, PhD</a>
</strong><br>
<span class="headline">Staff Engineer at BD (Becton Dickinson)</span>
</li>
<li class="with-photo">
<a href="http://www.linkedin.com/pub/steven-karuppan/5/293/a26?trk=pub-pbmap">
<img src="http://s.c.lnkd.licdn.com/scds/common/u/img/spacer.gif" data-li-src="http://m.c.lnkd.licdn.com/mpr/mpr/shrink_40_40/p/1/005/087/26b/0317fec.jpg" id="img-defer-id-6-4706" class="img-defer-hidden img-defer photo" width="40" height="40" alt="Steven Karuppan">
</a>
<strong>
<a href="http://www.linkedin.com/pub/steven-karuppan/5/293/a26?trk=pub-pbmap">Steven Karuppan</a>
</strong><br>
<span class="headline">CEO &amp; Co-founder at Blinded Diagnostics...</span>
</li>
<li class="with-photo">
<a href="http://www.linkedin.com/pub/michael-mcmanus/23/4a3/8b2?trk=pub-pbmap">
<img src="http://s.c.lnkd.licdn.com/scds/common/u/img/spacer.gif" data-li-src="http://m.c.lnkd.licdn.com/mpr/mpr/shrink_40_40/p/2/000/11e/005/0c5388c.jpg" id="img-defer-id-7-4706" class="img-defer-hidden img-defer photo" width="40" height="40" alt="Michael McManus">
</a>
<strong>
<a href="http://www.linkedin.com/pub/michael-mcmanus/23/4a3/8b2?trk=pub-pbmap">Michael McManus</a>
</strong><br>
<span class="headline">President and CEO at Misonix Inc</span>
</li>
</ul>
</div>
</div>
<div class="leo-module mod-util same-name-search">
<div class="header">
<h3><strong>Find a different Tim Maguire:</strong></h3>
</div>
<div class="content">
<ul>
<li>
<h4><a href="http://ca.linkedin.com/pub/tim-maguire/36/206/b81" rel="">Tim Maguire</a>, President at CUPE Local 79</h4>
<p class="location">Toronto, Canada Area</p>
</li>
<li>
<h4><a href="http://www.linkedin.com/in/timmaguire" rel="">Tim Maguire</a>, Field Service Manager - US Direct Employees at Emerson Process Management</h4>
<p class="location">Lakeland, Florida Area</p>
</li>
<li>
<h4><a href="http://www.linkedin.com/pub/timothy-maguire/15/758/665" rel="">Timothy Maguire</a>, Mid Market Account Executive at Pardot</h4>
<p class="location">Greater New York City Area</p>
</li>
<li>
<h4><a href="http://www.linkedin.com/pub/timothy-j-maguire/57/177/6b7" rel="">Timothy J. Maguire</a>, Project Manager - Moretrench</h4>
<p class="location">Greater New York City Area</p>
</li>
<li>
<h4><a href="http://www.linkedin.com/pub/tim-maguire/2/411/a6b" rel="">Tim Maguire</a>, </h4>
<p class="location">San Francisco Bay Area</p>
</li>
</ul>
<p class="more">
<a href="/pub/dir/?first=Tim&amp;last=Maguire" tracking="ppro_find_others">
More professionals named <span><strong>Tim Maguire</strong> &raquo;</span>
</a>
</p>
</div>
</div>
</div>
<div class="ad-block">
<script type="text/javascript">var dbl_page='public_profile';</script>
<script type="text/javascript">//<![CDATA[
var dbl_src="http://ad.doubleclick.net/adj/linkedin.dart/"+dbl_page+";lang=en;tile=1;dcopt=ist;sz=300x250;;;company=4262;company=2547326;company=1645;pcntry=us;s=0;ord="+Math.random()*10000000000000000+"?";document.write('<sc'+'ript src="'+dbl_src+'" type="text/javascript"><\/scr'+'ipt>');
//]]></script>
</div>
</div>
</div>
</div>
<script type="text/javascript">LI.Controls.processQueue();</script>
<div id="footer">
<div class="wrapper">
<div id="directory" class="us">
<h3>
LinkedIn member directory - Browse members <a href="/static?key=country_listing">by country</a>
</h3>
<ol type="a" class="primary">
<li>
<a href="/directory/people-a">a</a>
</li>
<li>
<a href="/directory/people-b">b</a>
</li>
<li>
<a href="/directory/people-c">c</a>
</li>
<li>
<a href="/directory/people-d">d</a>
</li>
<li>
<a href="/directory/people-e">e</a>
</li>
<li>
<a href="/directory/people-f">f</a>
</li>
<li>
<a href="/directory/people-g">g</a>
</li>
<li>
<a href="/directory/people-h">h</a>
</li>
<li>
<a href="/directory/people-i">i</a>
</li>
<li>
<a href="/directory/people-j">j</a>
</li>
<li>
<a href="/directory/people-k">k</a>
</li>
<li>
<a href="/directory/people-l">l</a>
</li>
<li>
<a href="/directory/people-m">m</a>
</li>
<li>
<a href="/directory/people-n">n</a>
</li>
<li>
<a href="/directory/people-o">o</a>
</li>
<li>
<a href="/directory/people-p">p</a>
</li>
<li>
<a href="/directory/people-q">q</a>
</li>
<li>
<a href="/directory/people-r">r</a>
</li>
<li>
<a href="/directory/people-s">s</a>
</li>
<li>
<a href="/directory/people-t">t</a>
</li>
<li>
<a href="/directory/people-u">u</a>
</li>
<li>
<a href="/directory/people-v">v</a>
</li>
<li>
<a href="/directory/people-w">w</a>
</li>
<li>
<a href="/directory/people-x">x</a>
</li>
<li>
<a href="/directory/people-y">y</a>
</li>
<li>
<a href="/directory/people-z">z</a>
</li>
<li>
<a href="/directory/people-1" class="callout-trigger nlcl-hovercard-trigger">more</a>
</li>
</ol>
</div>
<p id="terms-of-use">
By using this site, you agree to LinkedIn's <a rel="nofollow" href="/static?key=user_agreement&trk=ftr_useragre">terms of use</a>. Commercial use of this site without express authorization is prohibited.
</p>
<p id="copyright">LinkedIn Corporation &copy; 2014</p>
<ul id="nav-legal">
<li><a href="/static?key=user_agreement&amp;trk=hb_ft_userag">User Agreement</a></li>
<li><a href="/static?key=privacy_policy&amp;trk=hb_ft_priv">Privacy Policy</a></li>
<li><a href="/legal/cookie-policy">Cookie Policy</a></li>
<li class="last"><a href="/static?key=copyright_policy&amp;trk=hb_ft_copy">Copyright Policy</a></li>
</ul>
</div>
</div>
<script type="text/javascript">if(!window.LI){window.LI={};}
LI.RUM=LI.RUM||{};(function(RUM,win){var doc=win.document;RUM.flags=RUM.flags||{};RUM.flags['host-flag']="control";RUM.flags['pop_beacons_frequency']="n100-ap0-la0-va0-sg0-db0";RUM.flags['rs_timings_individual']="control";RUM.urls=RUM.urls||{};RUM.urls['rum-track']="/lite/rum-track?csrfToken=ajax%3A3149088565232137545";RUM.urls['boomerang-bw-img']="http://s.c.lnkd.licdn.com/scds/common/u/lib/boomerang/0.9.edge.4ab208445a/img/";RUM.base_urls=RUM.base_urls||{};RUM.base_urls['permanent_content']="http://s.c.lnkd.licdn.com/scds/common/u/";RUM.base_urls['versioned_content']="http://s.c.lnkd.licdn.com/scds/concat/common/";RUM.base_urls['media_proxy']="http://m.c.lnkd.licdn.com/media-proxy/";RUM.serverStartTime=1.41397315192E12;RUM.enabled=true;function getRumScript(){var node=doc.body||doc.head||doc.getElementsByTagName('head')[0],script=doc.createElement('script');script.src=["http://s.c.lnkd.licdn.com/scds/concat/common/js?h=ed29nkjpsa16bhrjq4na16owq-1mucgfycc664m7vmhpjgqse65-1l5rurej3h44qodo5rn0cdvyn-8om6v2ckrxsbnwf40t9ta8a7e-2yezjajdf67kcjm20w5zvv4kl-eaoqba5qd53ry9engxzq6km5n-e26o84ngs5prqitodnqpoj8y7-1m0whdrwis44c1hoa9mrwhlt4-aac54ic1fmca5xz1yvc5t9nfe-2soff02n1198o7v7c8f0beqva&fc=2"][0];node.appendChild(script);}
if(win.addEventListener){win.addEventListener('load',getRumScript);}
else{win.attachEvent('onload',getRumScript);}}(LI.RUM,window));</script>
<script type="text/javascript">if(window.LI&&LI.showAllDeferredImg&&!LI.imgDeferFoldCheckDone){LI.showAllDeferredImg(null,false);}</script>
<script id="localChrome"></script>
<script type="text/javascript">var _gaq=_gaq||[];_gaq.push(['_setAccount','UA-3242811-1']);_gaq.push(['_setDomainName','.linkedin.com']);_gaq.push(['_trackPageview','nprofile-public-success']);_gaq.push(['_setVar','guest']);YEvent.on(window,'load',function(){YAHOO.util.Get.script("http://www.google-analytics.com/ga.js");});</script>
<script type="text/javascript">//<![CDATA[
(function(){var bcookie=escape(LI.readCookie("bcookie")),newTrkInfo='5467724,'+document.referrer.substr(0,128),alias_secure='https://www.linkedin.com/analytics/noauthtracker?type=leo%2EpageTracking&pageType=full_page&pageKey=nprofile-public-success_jsbeacon&trkInfo=REPLACEME',alias_normal='/analytics/noauthtracker?type=leo%2EpageTracking&pageType=full_page&pageKey=nprofile-public-success_jsbeacon&trkInfo=REPLACEME',is_secure=false,url=(is_secure)?alias_secure:alias_normal;url=url.replace("REPLACEME",newTrkInfo);if(bcookie){if(window.$&&$.ajax){$.ajax(url);}else{YAHOO.util.Connect.asyncRequest('get',url,{});}}})();
//]]></script>
<script type="text/javascript">LI_WCT(["control-http-12248-exec-744691-1","control-http-12248-exec-744692-2","control-http-12248-exec-744692-3","control-http-12248-exec-744693-4","control-http-12248-exec-744693-5","control-http-12248-exec-744693-6","control-http-12248-exec-744694-7","control-http-12248-exec-744694-8","control-http-12248-exec-744694-9","control-http-12248-exec-744698-10","control-http-12248-exec-744703-11","control-http-12248-exec-744703-12",]);</script>
<script type="text/javascript">LI.Controls.processQueue();</script>
<script type="text/javascript">LI.define('Tracking.Comscore');LI.Tracking.Comscore=function(){YAHOO.util.Get.script('http://b.scorecardresearch.com/beacon.js',{onSuccess:function(){COMSCORE.beacon({c1:2,c2:6402952,c3:"",c4:"",c5:"",c6:"",c15:""});}});};YEvent.on(window,'load',LI.Tracking.Comscore);</script>
<noscript>
<img src="http://b.scorecardresearch.com/b?c1=2&amp;c2=6402952&amp;c3=&amp;c4=&amp;c5=&amp;c6=&amp;c15=&amp;cv=1.3&amp;cj=1" style="display:none" width="0" height="0" alt=""/>
</noscript>
<script type="text/javascript">LI.define('Tracking.Quantcast');LI.Tracking.Quantcast=function(){_qoptions={qacct:"p-b3sGjMtCFrexE"};YAHOO.util.Get.script('http://edge.quantserve.com/quant.js');};YEvent.on(window,'load',LI.Tracking.Quantcast);</script>
<noscript>
<a href="http://www.quantcast.com/p-b3sGjMtCFrexE" target="_blank"><img src="http://pixel.quantserve.com/pixel/p-b3sGjMtCFrexE.gif" style="display: none;" height="1" width="1" alt=""/></a>
</noscript>
<script type="text/javascript">YEvent.on(window,'load',function(){(function(){var protocol='http:';var d=new Image(1,1);d.onerror=d.onload=function(){d.onerror=d.onload=null;};d.src=[protocol,"//secure-us.imrworldwide.com/cgi-bin/m?ci=us-603751h&cg=0&cc=1&si=",escape(window.location.href),"&ts=compact&rnd=",(new Date()).getTime()].join('');})();});</script>
<noscript>
<img src="http://secure-us.imrworldwide.com/cgi-bin/m?ci=us-603751h&cg=0&cc=1&ts=noscript" width="1" height="1" alt="" style="display:none"/>
</noscript>
<script type="text/javascript">YEvent.on(window,'load',function(){(function(){var d=new Image(1,1);d.onerror=d.onload=function(){d.onerror=d.onload=null;};d.src="/csp/dtag?p=10";})();});</script>
<noscript>
<img src="/csp/dtag?p=10" width="1" height="1" alt="" style="display:none"/>
</noscript>
</body>
</html>
